← Back to Search

Behavioural Intervention

AR Pain Assessment App for Pediatric Cancer

Phase < 1
Waitlist Available
Led By Christina York
Research Sponsored by ALTality, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current diagnosis of pediatric cancer
Ages 7-17 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately after the intervention/procedure/surgery
Awards & highlights
No Placebo-Only Group

Summary

This trial will test an augmented reality tool in both English and Spanish to help Hispanic/Latino children and teens with cancer assess their pain, nausea, and vomiting after surgery. If successful, the tool

Who is the study for?
This trial is for Hispanic/Latino children and adolescents with cancer who are recovering from surgery. It's designed to help those who speak Spanish, English, or both. The goal is to test an app that could make it easier for them to communicate their pain levels in hospitals.
What is being tested?
The study is testing a mobile augmented reality (AR) app that helps assess pain, nausea, and vomiting in pediatric cancer patients post-surgery. This bilingual tool aims to improve care by bridging language barriers between patients and healthcare providers.
What are the potential side effects?
Since the intervention involves using an AR app for communication rather than a drug or medical procedure, there are no direct physical side effects expected from this technology.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently diagnosed with cancer as a child.
Select...
I am between 7 and 17 years old.
Select...
I am having surgery for cancer that will require me to stay in the hospital afterwards.
Select...
I will be given opioids for pain around the time of my surgery.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after the intervention/procedure/surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after the intervention/procedure/surgery for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Primary; Percent of enrolled patients who activated/used the app during the PACU stay
Secondary study objectives
Inpatient opioid consumption
Length of stay
Patient/caregiver satisfaction survey
+5 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Augmented reality-enabled pain assessment deployed on a mobileExperimental Treatment1 Intervention
Age-stratified (age 7-11 and age 12-17 years old) augmented reality app to evaluate for pain and opioid-related adverse events with equivalent English and Spanish text, audio, and narration

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterOTHER
3,053 Previous Clinical Trials
1,798,733 Total Patients Enrolled
ALTality, Inc.Lead Sponsor
1 Previous Clinical Trials
20 Total Patients Enrolled
Christina YorkPrincipal InvestigatorALTality, Inc.
1 Previous Clinical Trials
20 Total Patients Enrolled
~6 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top